Retatrutide
A next-generation incretin-class molecule engineered to engage three metabolic receptors simultaneously.
$139.00 USD / vial
Vial size
Research use only. This material is supplied exclusively for lawful in-vitro laboratory research, analytical testing, and scientific study by qualified professionals. Not for human or veterinary use of any kind.
About Retatrutide
Retatrutide is a synthetic peptide engineered as a triple agonist of the GIP, GLP-1, and glucagon receptors. It represents the current frontier of incretin research chemistry, extending the dual-agonist concept into simultaneous three-receptor engagement.
As one of the most closely watched molecules in metabolic science, it is in high demand for receptor-pharmacology and comparative incretin studies. Supplied lyophilized in three research quantities, each lot independently verified.
Documented research areas
- Multi-receptor incretin pharmacology
- GIP / GLP-1 / glucagon receptor studies
- Comparative metabolic-agonist research
- Peptide engineering and acylation chemistry
Technical profile
| CAS Number | 2381089-83-2 |
|---|---|
| Class | GIP/GLP-1/glucagon triple agonist |
| Molecular Weight | ≈ 4731 g/mol |
| Form | Lyophilized powder |
| Purity | ≥ 99% (HPLC) |
| Storage | −20 °C, protect from light |
Testing & documentation
Every production lot of Retatrutide is analyzed by an independent third-party laboratory before release. Identity is confirmed by mass spectrometry and purity is quantified by high-performance liquid chromatography (HPLC), with a minimum release threshold of 99%.
A lot-specific Certificate of Analysis is available on request, email support@elevatebiolabs.co. Vials are filled and sealed under laboratory-standard conditions and shipped in tamper-evident packaging.